BioHarvest Sciences (XCNQ:BHSC) Debt-to-Equity : -1.50 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Debt-to-Equity?

BioHarvest Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$28.06 Mil. BioHarvest Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$1.91 Mil. BioHarvest Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$-19.93 Mil. BioHarvest Sciences's debt to equity for the quarter that ended in Dec. 2023 was -1.50.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BioHarvest Sciences's Debt-to-Equity or its related term are showing as below:

XCNQ:BHSC' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.78 Med: -1.04 Max: 1.58
Current: -1.5

During the past 10 years, the highest Debt-to-Equity Ratio of BioHarvest Sciences was 1.58. The lowest was -1.78. And the median was -1.04.

XCNQ:BHSC's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.4 vs XCNQ:BHSC: -1.50

BioHarvest Sciences Debt-to-Equity Historical Data

The historical data trend for BioHarvest Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Debt-to-Equity Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-1.04

0.93

-1.78

-1.50

BioHarvest Sciences Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															-2.22	-1.78	-1.48	-1.48	-1.50

Competitive Comparison of BioHarvest Sciences's Debt-to-Equity

For the Packaged Foods subindustry, BioHarvest Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioHarvest Sciences's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Debt-to-Equity falls into.

BioHarvest Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BioHarvest Sciences's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(28.061	+	1.912)	/	-19.927
	=	-1.50

BioHarvest Sciences's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(28.061	+	1.912)	/	-19.927
	=	-1.50

BioHarvest Sciences (XCNQ:BHSC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BioHarvest Sciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CNVCF:USA 8MV:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines